Pharmalive - The Pulse of the Pharmaceutical Industry


Search Criteria: Search In:  
Conferences
 
Mar 18, 2010
TORONTO and WINNIPEG, March 17 /CNW/ - Cangene Corporation today reports that it has received European Commission approval to market Cangene's ImmunoGam (Human Hepatitis B Immunoglobulin), indicated for immunoprophylaxis of hepatitis B. This

NORWALK, Conn.--(BUSINESS WIRE)--Mar 16, 2010 - IMS Health today announced that 17 high-growth pharmaceutical markets are now ranked as “pharmerging,” up from seven currently, reflecting an unprecedented shift of industry growth to the world's emerging economies.

Vancouver, BC, March 16, 2010— Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced today the initiation of a new research collaboration with Pfizer. Tekmira and Pfizer will collaborate on evaluating Tekmira’s stable nucleic acid-lipid particle (SNALP) technology to deliver small interfering RNA (siRNA) molecules provided by Pfizer.



ROCKVILLE, Md., March 17, 2010-The FDA posted on its website, yesterday, warning letters sent to Actavis and Sirion Therapeutics over promotional material. In the Actavis letter, the FDA criticized a Co-Pay Assistance Program brochure for Kadian calling it "false or misleading because they omit and minimize the serious risks associated with the drug." In the Sirion letter it called a professional sales aid and a professional z-card for Durezol also "false and misleading."

LAKE CHARLES, La., March 17 /PRNewswire/ -- Everyone has heard of Botox being used to reduce the appearance of fine lines and wrinkles, but now the muscle-immobilizing treatment is moving to the opposite end of the body to get patients back on their feet.

NEWTOWN, Pa.--(BUSINESS WIRE)--Mar 16, 2010 - Quinnova Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and markets novel topical delivery platform-based prescription drugs, today announced the launch of its Neosalus Cream.

Naarden, The Netherlands; Malvern, PA, 16 March 2010 – Forbion Capital Partners today announces that it has led the Series C investment of Promedior with a syndicate of leading life science investors.

Oslo, 16 March 2010 - PCI Biotech reported today that it has completed the treatment of the third dose group in the phase I/II study of its proprietary photosensitiser Amphinex used in combination with the cytotoxic agent bleomycin in cancer patients.

BENSALEM, Pa.--(BUSINESS WIRE)--Mar 16, 2010 - Law Offices of Howard G. Smith, representing investors of Medivation, Inc., has filed a class action lawsuit in United States District Court on behalf of a class consisting of all persons or entities who purchased Medivation common stock between July 17, 2008 and March 2, 2010, inclusive.

TOKYO--(BUSINESS WIRE)--Mar 16, 2010 - Hitachi, Ltd. and NextDocs Corporation today announced their newly formed partnership in document management solutions for pharmaceutical manufacturers.

MANCHESTER, England--(BUSINESS WIRE)--Mar 16, 2010 - Dove Medical Press, a leading open-access publisher, has entered into an alliance with Athena Healthcare Consultancy, a well established CRO and pharmaceutical medical marketing consultancy based in Shanghai.

WASHINGTON--(BUSINESS WIRE)--Mar 16, 2010 - The U.S.-India Business Council (USIBC) today convened leading executives from U.S. and Indian industry, joined by top government officials, for the 7th Meeting of the U.S.-India High Technology Cooperation Group (HTCG).

REDWOOD CITY, Calif. & LONDON--(BUSINESS WIRE)--Mar 16, 2010 - Ingres Corporation, the leading open source database management company and pioneer of the New Economics of IT, today announced that AAH Pharmaceuticals Ltd., the UK's leading distributor of pharmaceutical and healthcare products and services to pharmacies, hospitals, and doctors, has significantly reduced operating costs with Ingres Database.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Mar 16, 2010 - Acacia Research Corporation announced today that its Hospital Systems Corporation subsidiary has entered into a license agreement with Carestream Health, Inc. covering a portfolio of patents that apply to medical picture archiving and communication system (PACS) technology.

RALEIGH, N.C.--(BUSINESS WIRE)--Mar 16, 2010 - MedThink Communications, a full-service healthcare communications company, today announced that Michael Szumera has joined the agency as Vice President, Public Relations Practice Lead.

LAFAYETTE, Colo.--(BUSINESS WIRE)--Mar 16, 2010 - Aegis Analytical Corp., the leading provider of Enterprise Manufacturing Intelligence software, announced today that Human Genome Sciences, Inc. will deploy Aegis' Discoverant as its data management, analytics and reporting solution in the scale-up and production of BENLYSTA (belimumab), an investigational drug for the treatment of systemic lupus that has successfully completed Phase 3 trials.

MADISON, Wis.--(BUSINESS WIRE)--Mar 16, 2010 - REACH3, the market leader in Customer Relationship Management (CRM) solutions for healthcare, has hired Lori Brenner, Director – Physician Referral Builder, effective March 9, 2010.

LOS ANGELES--(BUSINESS WIRE)--Mar 16, 2010 - DestinationRx, Inc., a health plan and drug comparison industry leader, was awarded the Healthcare Information and Management System Society (HIMSS) Medical Banking Project's “Point-and-Click” Award for 2010.

NEWTON, Mass.--(BUSINESS WIRE)--Mar 16, 2010 - Recombinant Data Corp., a healthcare data warehousing and clinical intelligence solutions provider, today announced that Harvard University selected the company to become an authorized support provider for Profiles Research Networking Software.

RALEIGH, N.C.--(BUSINESS WIRE)--Mar 16, 2010 - BioPontis Alliance LLC announces a biomedical development partnership with a charter group of leading private and public universities. New York University (including NYU School of Medicine), University of Florida, the University of North Carolina at Chapel Hill and the University of Pennsylvania have entered into memorandums of understanding with BioPontis Alliance to facilitate the advancement of promising research discoveries.

NEW YORK--(BUSINESS WIRE)--Mar 16, 2010 - Public meetings are an effective way to disseminate accurate information to the public about communicable diseases, such as the H1N1 influenza virus, according to a new study by researchers from the University of Missouri and the Northern Kentucky Health Department.

 
Ask The Experts

MedAdNews
What are the main takeaways you had from the FDA hearings on social media ...
Asia is a rapidly growing market with deep traditional roots, so is this geographic ...
As I manage a community outreach program for a large hospital, I observe how ...

R&D Directions
Are there any ways to ameliorate the cardiac risks of a drug in development, if such ...
Do you see a discernable increase in demand for formulation development services ...
What are the one or two, in your opinion, most promising novel imaging techniques ...

Podcasts

The MedAdNews Show
Episode 1: Tax Terror
Download

Episode 2: The New FDA
Download

Webcasts

MedAdNews
Promotional Effectiveness with the Physician, Pharmacy, and Patient
Wednesday, March 3, 2010 2PM – 3PM EST
Register

Views on Patient Adherence
Tuesday, January 12, 2010 2:00 PM EDT
View Webinar

Improving Compliance Through Master Data Management and an Aggregate Spend Solution
Monday, September 21, 2009 2:00 PM EDT
View Webinar

R&D Directions
Investigator Site Solutions for Clinical Trials
Thursday, September 17, 2009
View Webinar

People on the Move: 4th Quarter 2009

Increase market share by reaching decision-making professionals within Pharma and Biotech, Drug Discovery, CROs, Drug and Medical Device Packaging, and Advertising & Marketing Services companies. Generate leads, identify companies experiencing growth, and recruit successful business leaders. PURCHASE NOW – SAVE $149. – SAVE $70!

Learn More

Med Ad News
R&D Directions
Special Reports
Conferences


User Tools
Subscriber registration Purchase a subscription Forget your password Need help? Your account details Order back issues Renew subscription Advertise
©2010 Canon Communications Pharmaceutical Media Group